What is a stock summary page? Click here for an overview.
Business Description
Klotho Neurosciences Inc
NAICS : 541714
SIC : 2833
ISIN : US03465T1088
Description
Klotho Neurosciences Inc is in the development of patented, novel disease-modifying technologies targeting the brain and central nervous system (CNS) that are seen as key developments in treating neurodegenerative and age-related disorders.
Financial Strength
6/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Cash-To-Debt | 0.34 | |||||
Equity-to-Asset | 0.59 | |||||
Debt-to-Equity | 0.1 | |||||
Debt-to-EBITDA | -0.04 | |||||
Piotroski F-Score | N/A/9 | |||||
WACC vs ROIC |
Growth Rank
Name | Current | Vs Industry | Vs History |
---|
Momentum Rank
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
5-Day RSI | 46.66 | |||||
9-Day RSI | 41.13 | |||||
14-Day RSI | 39.43 | |||||
3-1 Month Momentum % | -24.26 | |||||
6-1 Month Momentum % | -52.53 |
Liquidity Ratio
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Current Ratio | 0.16 | |||||
Quick Ratio | 0.16 | |||||
Cash Ratio | 0.05 |
Dividend & Buy Back
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Shareholder Yield % | -8.07 |
Profitability Rank
1/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
ROE % | -4536.67 | |||||
ROA % | -150.94 | |||||
ROIC % | -136.72 | |||||
ROCE % | -283.84 |
GF Value Rank
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
PB Ratio | 3.72 | |||||
EV-to-EBIT | -1.93 | |||||
EV-to-EBITDA | -1.93 | |||||
EV-to-FCF | -3.66 | |||||
Earnings Yield (Greenblatt) % | -51.81 | |||||
FCF Yield % | -30.17 |
Operating Revenue by Business Segment
Operating Revenue by Geographic Region
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsGurus Latest Trades with NAS:KLTO
You need a Premium membership or above to view this section.
Take a 7-Day Free Trial
No Available Data
Peter Lynch Chart
Performance
Dividend
Log
Bar
Annualized Return % Â
Total Annual Return % Â
Klotho Neurosciences Inc Executives
DetailsGF Value
Analyst Estimate
Key Statistics
Name | Value | ||
---|---|---|---|
Revenue (TTM) (Mil $) | |||
EPS (TTM) ($) | -0.211 | ||
Beta | - | ||
3-Year Sharpe Ratio | - | ||
3-Year Sortino Ratio | - | ||
Volatility % | - | ||
14-Day RSI | 39.43 | ||
14-Day ATR ($) | 0.034834 | ||
20-Day SMA ($) | 0.2982 | ||
12-1 Month Momentum % | - | ||
52-Week Range ($) | 0.257 - 5.11 | ||
Shares Outstanding (Mil) | 27.08 |
Piotroski F-Score Details
Year:
Component | Result | ||
---|---|---|---|
Piotroski F-Score | 9999 | ||
Positive ROA | |||
Positive CFROA | |||
Higher ROA yoy | |||
CFROA > ROA | |||
Lower Leverage yoy | |||
Higher Current Ratio yoy | |||
Less Shares Outstanding yoy | |||
Higher Gross Margin yoy | |||
Higher Asset Turnover yoy |
Klotho Neurosciences Inc Filings
Filing Date | Document Date | Form | ||
---|---|---|---|---|
No Filing Data |
Klotho Neurosciences Inc Stock Events
Event | Date | Price ($) | ||
---|---|---|---|---|
No Event Data |
Klotho Neurosciences Inc Frequently Asked Questions
What is Klotho Neurosciences Inc(KLTO)'s stock price today?
The current price of KLTO is $0.26. The 52 week high of KLTO is $5.11 and 52 week low is $0.26.
When is next earnings date of Klotho Neurosciences Inc(KLTO)?
The next earnings date of Klotho Neurosciences Inc(KLTO) is .
Does Klotho Neurosciences Inc(KLTO) pay dividends? If so, how much?
Klotho Neurosciences Inc(KLTO) does not pay dividend.
Press Release
Subject | Date | |||
---|---|---|---|---|
No Press Release |